EP2418202
(4-[4-[5-(substituted amino)-pyridin-2-yl]phenyl]-cyclohexyl)-acetic acid derivatives as DGAT inhibitors
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.3.2007EP published:
29.1.2014EP application number:
11158211.0
EPO information:
European Patent Register
Max expiry date:
27.3.2027
Title:
(4-[4-[5-(substituted amino)-pyridin-2-yl]phenyl]-cyclohexyl)-acetic acid derivatives as DGAT inhibitors
Timeline
Today
28.3.2007EP application
29.1.2014EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
Serrano-Wu, Michael HAddress:
Belmont, MA, US
Name:
Kwak, Young-ShinAddress:
Lexington, MA, US
Name:
Liu, WenmingAddress:
Morris Plains, NJ, US
Priority
Number:
787859 PDate:
31.3.2006Country:
US
Classification
Categories:
C07D 213/74, C07D 213/75, C07D 213/81, C07D 213/82, C07D 237/20, C07D 239/42, C07D 263/48, C07D 277/42, C07D 401/10, C07D 401/12, C07D 401/14, C07D 405/12, C07D 413/10, C07D 413/12, A61K 31/44, A61K 31/50, A61K 31/53, A61K 31/421, A61K 31/426